{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:33:11Z","timestamp":1785929591291,"version":"3.56.0"},"reference-count":74,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"Beijing municipal science and technology planning committee \u201cCapital Characteristics\u201d key project","award":["Z171100001017104"],"award-info":[{"award-number":["Z171100001017104"]}]},{"name":"Scientific research project of Chinese Society of Ethnic Medicine","award":["2021Z2072-340503"],"award-info":[{"award-number":["2021Z2072-340503"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.1080\/14740338.2024.2416918","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T08:50:41Z","timestamp":1729068641000},"page":"773-786","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["The effectiveness and safety of aripiprazole, bromocriptine, and cabergoline in the treatment of hyperprolactinemia: a systematic review and network meta-analysis"],"prefix":"10.1080","volume":"24","author":[{"given":"Kun","family":"Ma","sequence":"first","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Ma","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Huang","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlan","family":"Zhong","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Gao","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Luo","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-023-00886-5"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0920-9964(98)00158-3"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/00048674.2011.589044"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8529(18)30193-2"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165212"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0194-6"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.25457"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb03397.x"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/bf00273860"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1215"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000004818"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03752.x"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/07435800.2015.1135444"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112442016"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e328355e1ac"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1008-0805.2008.05.138"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2023-0504"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.7871"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070179"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.11919\/j.issn.1002-0829.215014"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.728204"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-010-0290-z"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-018-0217-3"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1337274"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-012-2106-0"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/bf03346845"},{"issue":"2","key":"e_1_3_7_30_1","first-page":"93","article-title":"Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia","volume":"13","author":"Ghaneei A","year":"2015","unstructured":"Ghaneei A, Jowkar A, Hasani Ghavam MR, et al. Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia. Iran J Reprod Med. 2015;13(2):93\u2013100.","journal-title":"Iran J Reprod Med"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/09513598709082710"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000898"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb01485.x"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2015.04.011"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139717"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06071075"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-017-1022-3"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.12.033"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1006-7884.2009.04.014"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.3870\/j.issn.1004-0781.2007.10.012"},{"issue":"5","key":"e_1_3_7_41_1","first-page":"569","article-title":"Dose-response relationship of aripiprazole in the treatment of female patients with hyperprolactinemia caused by risperidone","volume":"25","author":"Chen H","year":"2016","unstructured":"Chen H, Zhang R, Chen J, et al. Dose-response relationship of aripiprazole in the treatment of female patients with hyperprolactinemia caused by risperidone. Chin J New Drugs. 2016;25(5):569\u2013573.","journal-title":"Chin J New Drugs"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.11886\/j.issn.1007=3256.2015.03.008"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.7620\/zgfybj.j.issn.1001-4411.2017.14.60"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-3220.2023.06.001"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-0152.2019.10.006"},{"issue":"4","key":"e_1_3_7_46_1","first-page":"487","article-title":"Aripiprazole for antipsychotic hyperprolactinemia","volume":"21","author":"Guo J","year":"2013","unstructured":"Guo J, Cao C, Liao C, et al. Aripiprazole for antipsychotic hyperprolactinemia. Chin J Health Phychol. 2013;21(4):487\u2013489.","journal-title":"Chin J Health Phychol"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1009-7201.2008.06.022"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-4931.2017.14.021"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.13457\/j.cnki.jncm.2022.19.007"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.13457\/j.cnki.jncm.2016.06.067"},{"issue":"3","key":"e_1_3_7_51_1","first-page":"142","article-title":"Clinical study on the treatment of Chinese hyperprolactinaemia with Bushen Tiaogan Lianru recipe","volume":"18","author":"Liu J","year":"1998","unstructured":"Liu J, Wang J, Chen X, et al. Clinical study on the treatment of Chinese hyperprolactinaemia with Bushen Tiaogan Lianru recipe. Chin J Integr Tradit Chin West Med. 1998;18(3):142\u2013144.","journal-title":"Chin J Integr Tradit Chin West Med"},{"issue":"11","key":"e_1_3_7_52_1","first-page":"1288","article-title":"A controlled study of aripiprazole adjuvant therapy for antipsychotic hyperprolactinemia","volume":"19","author":"Liu L","year":"2011","unstructured":"Liu L, Qi S, Dong X, et al. A controlled study of aripiprazole adjuvant therapy for antipsychotic hyperprolactinemia. Chin J Health Phychol. 2011;19(11):1288\u20131290.","journal-title":"Chin J Health Phychol"},{"issue":"10","key":"e_1_3_7_53_1","first-page":"843","article-title":"Observation of the therapeutic effect of aripiprazole on hyperprolactinemia caused by antipsychotic","volume":"31","author":"Liu Z","year":"2011","unstructured":"Liu Z, Cao B, Jiao F, et al. Observation of the therapeutic effect of aripiprazole on hyperprolactinemia caused by antipsychotic. Chin J Hosp Pharm. 2011;31(10):843\u2013846.","journal-title":"Chin J Hosp Pharm"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-7386.2018.19.026"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.2095-9346.2016.04.002"},{"issue":"30","key":"e_1_3_7_56_1","first-page":"5157","article-title":"Bromocriptine\u2019s effect on gonadotropin ovulation in hyperprolactinaemia women","volume":"30","author":"Shi M","year":"2015","unstructured":"Shi M. Bromocriptine\u2019s effect on gonadotropin ovulation in hyperprolactinaemia women. Maternal Child Health Care China. 2015;30(30):5157\u20135159.","journal-title":"Maternal Child Health Care China"},{"issue":"13","key":"e_1_3_7_57_1","first-page":"19","article-title":"Therapeutic effect of aripiprazole on 75 cases of hyperprolactinemia induced by risperidone","volume":"24","author":"Tang P","year":"2015","unstructured":"Tang P, Feng J, Xia N. Therapeutic effect of aripiprazole on 75 cases of hyperprolactinemia induced by risperidone. Chin Pharma. 2015;24(13):19\u201320.","journal-title":"Chin Pharma"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-0217.2017.02.013"},{"issue":"12","key":"e_1_3_7_59_1","first-page":"1556","article-title":"Different serum prolactin levels after oral administration of bromocriptine in liver cirrhosis patients","volume":"13","author":"Wang Q","year":"2009","unstructured":"Wang Q, Zhang C, Jiao X, et al. Different serum prolactin levels after oral administration of bromocriptine in liver cirrhosis patients. Anhui Med. 2009;13(12):1556\u20131557.","journal-title":"Anhui Med"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-3220.2018.06.009"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-3220.2018.02.017"},{"issue":"8","key":"e_1_3_7_62_1","first-page":"1187","article-title":"The efficacy of aripiprazole in the treatment of antipsychotic hyperprolactinemia","volume":"22","author":"Wang Y","year":"2015","unstructured":"Wang Y, Lv B, He E. The efficacy of aripiprazole in the treatment of antipsychotic hyperprolactinemia. Primary Med China. 2015;22(8):1187\u20131189.","journal-title":"Primary Med China"},{"issue":"9","key":"e_1_3_7_63_1","first-page":"1606","article-title":"A clinical study of aripiprazole in relieving risperidone-induced prolactin elevation in female schizophrenic patients","volume":"18","author":"Wen N","year":"2016","unstructured":"Wen N, Tang W, Pan J, et al. A clinical study of aripiprazole in relieving risperidone-induced prolactin elevation in female schizophrenic patients. Clin Med Zhejiang province. 2016;18(9):1606\u20131608.","journal-title":"Clin Med Zhejiang province"},{"issue":"4","key":"e_1_3_7_64_1","first-page":"263","article-title":"Effect of aripiprazole on antipsychotic hyperprolactinemia in elderly patients with schizophrenia","volume":"23","author":"Wu H","year":"2013","unstructured":"Wu H, Lin D, Li Y, et al. Effect of aripiprazole on antipsychotic hyperprolactinemia in elderly patients with schizophrenia. J Clin Psychiatry. 2013;23(4):263\u2013264.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"e_1_3_7_65_1","first-page":"693","article-title":"Study on the effects of aripiprazole on hyperprolactinaemia induced by sulfadiazine","volume":"21","author":"Yang Y","year":"2016","unstructured":"Yang Y, Xia Y, Zhu C, et al. Study on the effects of aripiprazole on hyperprolactinaemia induced by sulfadiazine. Chin Clin Pharmacol Ther. 2016;21(6):693\u2013696.","journal-title":"Chin Clin Pharmacol Ther"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.14009\/j.issn.1672-2124.2020.08.016"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1003-3734.2018.03.015"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.13683\/j.wph.2015.05.013"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-5725.2015.02.050"},{"issue":"2","key":"e_1_3_7_70_1","first-page":"68","article-title":"Research on aripiprazole to prevent antipsychotic hyperprolactinaemia in women with schizophrenia","volume":"41","author":"Zhou P","year":"2014","unstructured":"Zhou P, Liu L, Hao J, et al. Research on aripiprazole to prevent antipsychotic hyperprolactinaemia in women with schizophrenia. Int J Psychiatry. 2014;41(2):68\u201372.","journal-title":"Int J Psychiatry"},{"issue":"2","key":"e_1_3_7_71_1","first-page":"98","article-title":"Gender differences in the efficacy of 10 mg aripiprazole in the treatment of risperidone-induced hyperprolactinemia","volume":"37","author":"Zhu Y","year":"2017","unstructured":"Zhu Y, Jin Z. Gender differences in the efficacy of 10 mg aripiprazole in the treatment of risperidone-induced hyperprolactinemia. Emerg Med China. 2017;37(s2):98\u201399.","journal-title":"Emerg Med China"},{"issue":"1","key":"e_1_3_7_72_1","first-page":"56","article-title":"Effects of different doses of aripiprazole on risperidone in the treatment of schizophrenia-induced hyperprolactinemia","volume":"44","author":"Zhuo D","year":"2017","unstructured":"Zhuo D, Wang G, Wang D, et al. Effects of different doses of aripiprazole on risperidone in the treatment of schizophrenia-induced hyperprolactinemia. Int J Psychiatry. 2017;44(1):56\u201359.","journal-title":"Int J Psychiatry"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.2165\/11208400-000000000-00000"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13678"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0160"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2416918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:42:52Z","timestamp":1751366572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2416918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,3]]}},"alternative-id":["10.1080\/14740338.2024.2416918"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2416918","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}